MyMD Pharmaceuticals Inc (MYMD)

[leifsmith]

MyMD-1: a precise tool where molecular hammers fail?

Many approaches to regulating NF-kB (and other causes of inflammation) have serious bad effects because they do too much. The value of anatabine citrate (in Anatabloc) is that it reduces only the harmful action of excess NF-kB.

MyMD-1, developed by the same researchers, also may provide such precision.

I'm speculating far beyond anything my actual knowledge justifies.